Market Overview:
The global ocular drug delivery system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising geriatric population, and technological advancements in ocular drug delivery systems. Based on type, the global ocular drug delivery system market is segmented into implantable ocular drug delivery systems and particulate drug delivery systems. The implantable ocular drug delivery systems segment is expected to grow at a CAGR of 8.0% from 2018 to 2030 due to the increasing demand for minimally invasive procedures and rising prevalence of eye diseases. Based on application, the global ocular drug delivery system market is segmented into hospitals, clinics, ambulatory surgical centers (ASCs), and others (research institutes & academic institutions). The hospitals segment accounted for the largest share of the global ophthalmic drugs Delivery System Market in 2017 owing to factors such as growing number of surgeries performed in hospitals and rising demand for advanced treatments options.
Product Definition:
An ocular drug delivery system is a device that is used to administer medication to the eye. The importance of an ocular drug delivery system is that it allows for the direct administration of medication to the eye, which can help to improve treatment outcomes.
Implantable Ocular Drug Delivery Systems:
Implantable ocular drug delivery systems are a class of devices used to deliver drugs to the eye. They are implanted in the eye and allow for continuous or periodic administration of drugs.
Particulate Drug Delivery Systems:
Particulate drug delivery systems are small particles that can be used to deliver drugs to the site of action with high efficiency. They have several advantages over other forms of ocular drug delivery system, which include minimum side effects and easy availability. The particulate systems are widely used in eye drops for treating conjunctivitis, blepharospasm, and dry eyes among others.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and ambulatory surgical centers. The clinics segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of ocular diseases requiring drug delivery systems at an early stage. According to Eye Bank Association of America, around 60 million Americans aged more than 50 years suffer from some form of eye disease which requires treatment. Thus, due to a large patient base with various ocular disorders requiring regular check-ups and monitoring procedures for improving vision at an early stage, clinics emerged as one of the largest segments driving demand for ODDDS globally during the forecast period.
The hospital segment is expected to witness lucrative growth over the forecast period owing to increasing cases relatedto eye disorders such as cataract extraction surgery performed in hospitals or optical care units by surgeons every day across various regions globally.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and well-established healthcare infrastructure. Moreover, increasing prevalence of ocular disorders such as dry eye disease (DED), glaucoma, and other diseases associated with increased risk for developing DME is also expected to drive growth. According to an article published in NCBI, approximately 3 million people suffer from DED in the U.S., which results into decreased vision due to damage or dysfunction of the delicate eye tissue called cornea.
Growth Factors:
- Increasing prevalence of eye diseases: The global prevalence of blindness is estimated to be around 7.5 million, and the number of people with visual impairment is expected to grow to 8.2 million by 2020. This will create a large potential market for ocular drug delivery systems.
- Growing demand for minimally invasive procedures: There is growing demand for minimally invasive procedures, as they are less painful and have shorter recovery times than traditional surgery. Ocular drug delivery systems offer an attractive alternative to traditional surgery and are likely to gain popularity in the coming years.
- Advances in technology: Technological advances are paving the way for new ocular drug delivery systems that are more efficient and effective than older ones. This will help boost the growth of the market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ocular Drug Delivery System Market Research Report
By Type
Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
Ocular Therapeutix, Alimera Sciences, Allergan, Graybug Vision, Bausch Health, EyePoint Pharmaceuticals, Santen Pharmaceutical, Taiwan Liposome, Envisia Therapeutics, Clearside Biomedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Ocular Drug Delivery System Market Report Segments:
The global Ocular Drug Delivery System market is segmented on the basis of:
Types
Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ocular Therapeutix
- Alimera Sciences
- Allergan
- Graybug Vision
- Bausch Health
- EyePoint Pharmaceuticals
- Santen Pharmaceutical
- Taiwan Liposome
- Envisia Therapeutics
- Clearside Biomedical
Highlights of The Ocular Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Implantable Ocular Drug Delivery Systems
- Particulate Drug Delivery Systems
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ocular Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An ocular drug delivery system (ODDS) is a device that helps deliver medications to the eye. ODs can be in the form of pills, drops, or patches.
Some of the major companies in the ocular drug delivery system market are Ocular Therapeutix, Alimera Sciences, Allergan, Graybug Vision, Bausch Health, EyePoint Pharmaceuticals, Santen Pharmaceutical, Taiwan Liposome, Envisia Therapeutics, Clearside Biomedical.
The ocular drug delivery system market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ocular Drug Delivery System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ocular Drug Delivery System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ocular Drug Delivery System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ocular Drug Delivery System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ocular Drug Delivery System Market Size & Forecast, 2020-2028
4.5.1 Ocular Drug Delivery System Market Size and Y-o-Y Growth
4.5.2 Ocular Drug Delivery System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Implantable Ocular Drug Delivery Systems
5.2.2 Particulate Drug Delivery Systems
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ocular Drug Delivery System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ocular Drug Delivery System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Implantable Ocular Drug Delivery Systems
9.6.2 Particulate Drug Delivery Systems
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Implantable Ocular Drug Delivery Systems
10.6.2 Particulate Drug Delivery Systems
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Implantable Ocular Drug Delivery Systems
11.6.2 Particulate Drug Delivery Systems
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Implantable Ocular Drug Delivery Systems
12.6.2 Particulate Drug Delivery Systems
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Implantable Ocular Drug Delivery Systems
13.6.2 Particulate Drug Delivery Systems
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ocular Drug Delivery System Market: Competitive Dashboard
14.2 Global Ocular Drug Delivery System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ocular Therapeutix
14.3.2 Alimera Sciences
14.3.3 Allergan
14.3.4 Graybug Vision
14.3.5 Bausch Health
14.3.6 EyePoint Pharmaceuticals
14.3.7 Santen Pharmaceutical
14.3.8 Taiwan Liposome
14.3.9 Envisia Therapeutics
14.3.10 Clearside Biomedical
